Looking to publish in Intestinal Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowIntestinal Research is a quarterly journal focused on inflammatory bowel disease and related gastroenterology topics. It publishes review articles and original articles, has print ISSN 1598-9100 and online ISSN 2288-1956, and reports an impact factor of 3.9 in Gastroenterology & Hepatology.
Looking to publish in Intestinal Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Intestinal Research accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review
Case Report
Statement
Letter To The Editor
Brief Communication
Recent Publications
Rapid diagnosis and therapeutic mitigation in inflammatory bowel disease: utilizing the window of opportunity–findings from the UAE Epi-IBD study
Thaer Khaleel Swaid, Layth Raafat Hamzeh, Laurette L. Bukasa, Tine Jess, Mohammed Nabil Quraishi
Utilizing intestinal ultrasound to assess treatment response in ulcerative colitis
Shintaro Sagami, Taku Kobayashi
Incidence and treatment-based risk stratification of opportunistic infections in patients with inflammatory bowel disease: an ambispective cohort study in Brazil
Rios Ricci José Eugenio, Tarsila Campanha da Rocha Ribeiro, Fernando Antonio Basile Colugnati, Lívia de Almeida Costa, Pedro de Morais, Jordana AS Lopes, Hugo B Araújo, Matheus A Pacheco, Mariana V de S Paulo, João Baptista de Paula Fraga, Lucélia Paula Cabral Schmidt, Thais de Andrade Almeida, Roberta Oliveira Raimundo Borsato, Liliana Andrade Chebli, Júlio Maria Fonseca Chebli
Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials
Hiroshi Nakase, Baili Chen, Qian Cao, Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Dong Il Park, Keira Herr, Bryan Wahking, Wai Chun Yiu, Jianmin Zhuo, Minhu Chen
Comments on “Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficultto- treat inflammatory bowel disease: a single-center retrospective study in Japan”
Chenchen Xu, Hailing Li
Frequently asked questions
How long does it take to publish?
Initial decision is normally made within 6 weeks on average of receipt of a manuscript. Revised manuscripts must be resubmitted within 8 weeks of the editorial decision. Corresponding authors must respond to manuscript editor revisions within 2 days and report proof errors within 2 days.
Reformat to Intestinal Research using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should state that the submission has not been published previously or is not under consideration elsewhere, disclose potential conflicts of interest, and include preprint posting information and the preprint link when applicable. Authors including minors or family members in the research should indicate this in the cover letter.
Reformat to Intestinal Research using Livewrite PremiumWhat are the publication costs?
Individual subscription: USD 10 per issue or USD 40 annually; institutional subscription: USD 12 per issue or USD 48 annually.
Reformat to Intestinal Research using Livewrite Premium